Fluoxymesterone, Mesterolone, Methyltestosterone, (see casodex more drug interactions anabolic steroids)Antiandrogens: Bicalutamide, Cyproterone, Dienogest, Flutamide, Nilutamide, SpironolactoneEstrogens:(receptor) ESTRADIOL, ESTRIOL, ESTRONE, Chlorotrianisene, Dienestrol, Diethylstilbestrol, Ethinylestradiol.

and is an oral non-steroidal anti-androgen with the empirical formula C18H14N2O4F4S and is an oral non-steroidal anti-androgen for prostate cancer. It was first launched in 1995 as a monotherapy. Has been used casodex more drug interactions clinical trials for ovarian cancer.[edit] casodex more drug interactions and precautionsBicalutamide casodex more drug interactions contra-indicated in females and children and must not be given to casodex more drug interactions patient who has shown a hypersensitivity reaction to its use.[edit] Adverse reactionsAdverse reactions include reproductive system and breast disorders, breast tenderness, gynaecomastia, hot flushes, gastrointestinal disorders, diarrhoea, nausea, hepatic changes (elevated levels of transaminases, jaundice), asthenia and pruritus.[edit] External linksCasodex, Cosudex (manufacturer's website)Bicalutamide casodex more drug interactions information)[hide]v • d • casodex more drug interactions hormones and related agents (primarily G03, casodex more drug interactions L02, H01C) - human endogenous in CAPSProgestogens:(receptor) PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol.

for prostate cancer. It was first launched in 1995 as a combination treatment (with surgical treatment.